Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease von Martin-Arranz, M. D., García-Ramírez, L., Hernandez-Perez, M., Montero Vega, D., Martín-Arranz, E., Sánchez-Azofra, M., Poza Cordon, J., Rueda Garcia, J. L., Noci Belda, J., Verges Martínez-Meco, T., Blanco San Miguel, P., Suarez Ferrer, C.

Volltext

Liver necrosis secondary to organophosphates intoxication von Adán-Merino, L, Gómez-Senent, S, Gea-Rodríguez, F, Alonso-Gamarra, E, Martín-Arranz, E, Segura-Cabral, J M

Volltext

Focal globular amyloidosis of the colon. An exceptional diagnosis von Martín-Arranz, E, Pascual-Turrión, J M, Martín-Arranz, M D, Burgos, E, Froilán-Torres, C, Adán-Merino, L, Lorenzo, A, Segura-Cabral, J M

Volltext

Linfoma MALT duodenal: una localización muy poco frecuente von Adán Merino, L., Martín Arranz, E., Mora Sanz, P., Froilán Torres, C., Martín Arranz, M. D., Gómez Senent, S., Suárez de Parga, J. M., Segura Cabral, J. M.

Volltext

Impacto emocional durante el confinamiento por COVID-19 en menores de hospital de día y en sus padres/cuidadores von C., Martín Arranz, E., Fernández Rodríguez, B., Carrascal Joral, E., Diez Revuelta, A.

Volltext

Dolor y cambios autonómicos en los brazos en una deportista von Iniesta Arandia, N, Fernández Capitán, M.C, Martín Arranz, E, Bret Zurita, M, García de Paso Mora, P, Valero Recio, J

Volltext

P737 Intensification with intravenous ustekinumab in refractory Crohn′s disease von Arroyo Argüelles, J M, Suárez Ferrer, C, Rueda García, J L, Martín-Arranz, E, Poza Cordón, J, Sánchez-Azofra, M, García-Ramírez, L, Martin-Arranz, M D

Volltext

P818 Survival of ustekinumab treatment based on concomitant immunomodulator use von García Ramírez, L, Suárez Ferrer, C, Rueda Garcia, J L, Martín-Arranz, E, Poza Cordón, J, Sánchez-Azofra, M, Martin-Arranz, M D

Volltext

P360 Role of intestinal ultrasound scores in the diagnosis of post-operative recurrence in Crohn's disease von Amor Costa, C, Suárez Ferrer, C, Poza Cordón, J, Yebra Carmona, J, Rueda García, J L, Sánchez Azofra, M, Martín Arranz, E, González Díaz, I, Amiama Roig, C, Martín Arranz, M D

Volltext

P151 Characterization of platelet activation profile in Inflammatory Bowel Disease von Rueda Garcia, J L, Martín Arranz, E, Ramírez García, L, Suárez Ferrer, C, Sánchez Azofra, M, Poza Cordón, J, Amiama Roig, C, Noci Belda, J, Perosanz, L, Cubillo García, C, García-Rojas, C, Silva, K, Monzón Manzano, E, Arias-Salgado, E G, Acuña, P, Butta, N, Martín Arranz, M D

Volltext

P679 What is the best strategy after failure to anti-TNF? Ustekinumab or other anti-TNF? von Cerpa Arencibia, A, Suarez Ferrer, C, Poza Cordón, J, Martín Arranz, E, Ramírez, L, Martín Arranz, M D

Volltext

P380 What is the optimal dose of thiopurinic drugs (azatioprine) in patients with inflammatory bowel disease under treatment combined with anti-TNFα (infliximab/adalimumab)? von LUCAS RAMOS, J, Suarez Ferrer, C, Sanchez Azofra, M, Poza Cordón, J, Martín Arranz, E, Martin Arranz, M D

Volltext

P211 Pseudopolyps are associated with increased fecal calprotectin levels in patients with Inflammatory Bowel Disease in clinical and endoscopic remission von Spigarelli De Rábago, I, Suárez Ferrer, C, Poza Cordón, J, Martín Arranz, E, Sánchez Azofra, M, Rueda García, J L, Suarez Cabredo, C G, Hernández Pérez, M, Martín Arranz, M D

Volltext

P473 Ustekinumab and vedolizumab influence on cardiovascular risk factors in patients with Inflammatory Bowel Disease von Amiama Roig, C, Suárez Ferrer, C, Poza Cordón, J, Rueda García, J L, Sánchez Azofra, M, Martín Arranz, E, González Díaz, I, Amor Costa, C, García Ramírez, L, Martín Arranz, M D

Volltext

P577 Withdrawal of thiopurines in patients with Ulcerative Colitis in remission von Amor Costa, C, Suárez Ferrer, C, Poza Cordón, J, Rueda García, J L, Sánchez Azofra, M, Martín Arranz, E, González Diaz, I, Amiama Roig, C, García Ramirez, L, Martín Arranz, M D

Volltext

P182 Bowel Preparation in inflammatory bowel diseases (IBD): preliminary results from a randomised trial evaluating efficacy, tolerability and safety of cleansing solutions in IBD... von Rueda Garcia, J L, Suárez Ferrer, C, Martín-Arranz, E, Poza, J, Sánchez-Azofra, M, García-Ramirez, L, Poladura, B, Verges, T, Noci, J, Martín-Arranz, M D

Volltext

Granulocitoaféresis selectiva durante la inducción con vedolizumab en colitis ulcerosa moderada-grave: experiencia en un hospital terciario von Ferrer, C Suárez, Arranz, E Martin, Martín-Arranz, M D

Volltext

P371 The addition of intravenous, high dose, bolus of methyl-prednisolone increases the early clinical response to oral corticosteroids in moderately active ulcerative colitis. Pre... von Domènech Moral PhD, E, Llaó, J, Mañosa, M, Martín-Arranz, E, Zabana, Y, Navarro-Llavat, M, Garcia-Planella, E, Busquets, D, Pineda, J R, Monfort, D, Gutiérrez, A, García-Alonso, F J, Menchén, L A, Villoria, A

Volltext

P546 Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease von Torres, N, Martín Arranz, D, Sánchez Azofra, M, Martín Arranz, E, Garcia, L, Nozal, P, Pascual, J, Apraiz, I, López, M, Arteta, D, Nagore, D

Volltext

Chronic hepatitis C treatment in a cystic fibrosis patient in the pulmonary pre-transplant stage von Adán-Merino, L, Olveira-Martín, A, Prados, C, Gea-Rodríguez, F, Castillo-Grau, P, Martín-Arranz, E, Sáenz, J C, Segura-Cabral, J M

Volltext